Cover Image
Market Research Report
Product code 
1061263

Global Personalized Medicine Market Insights and Forecast to 2028

Published: | QYResearch | 113 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Personalized Medicine Market Insights and Forecast to 2028
Published: March 1, 2022
QYResearch
Content info: 113 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

Market Analysis and Insights: Global Personalized Medicine Market

The global Personalized Medicine market size is projected to reach US$ 540120 million by 2028, from US$ 259380 million in 2021, at a CAGR of 10.9% during 2022-2028.

Fully considering the economic change by this health crisis, Personalized Medicine Diagnostics accounting for % of the Personalized Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oncology segment is altered to an % CAGR throughout this forecast period.

China Personalized Medicine market size is valued at US$ million in 2021, while the North America and Europe Personalized Medicine are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Personalized Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicine market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicine market.

Global Personalized Medicine Scope and Market Size

Personalized Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Personalized Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Personalized Medicine Diagnostics
  • Personalized Medical Care
  • Personalized Medicine Therapeutics
  • Personalized Nutrition and Wellness

Segment by Application

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory
  • Other Applications

By Company

  • Abbott Laboratories
  • Agilent Technologies
  • Amgen
  • Astellas Pharma
  • Astrazeneca
  • Bayer AG
  • Celgene Corporation
  • Glaxosmithkline Plc
  • Illumina
  • Johnson & Johnson
  • Laboratory Corporation
  • Merck
  • Novartis AG
  • Roche Holding AG
  • Siemens AG
  • Takeda Pharmaceutical Company Limited

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Personalized Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Personalized Medicine Diagnostics
    • 1.2.3 Personalized Medical Care
    • 1.2.4 Personalized Medicine Therapeutics
    • 1.2.5 Personalized Nutrition and Wellness
  • 1.3 Market by Application
    • 1.3.1 Global Personalized Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Oncology
    • 1.3.3 Central Nervous System (CNS)
    • 1.3.4 Immunology
    • 1.3.5 Respiratory
    • 1.3.6 Other Applications
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Personalized Medicine Market Perspective (2017-2028)
  • 2.2 Personalized Medicine Growth Trends by Region
    • 2.2.1 Personalized Medicine Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Personalized Medicine Historic Market Size by Region (2017-2022)
    • 2.2.3 Personalized Medicine Forecasted Market Size by Region (2023-2028)
  • 2.3 Personalized Medicine Market Dynamics
    • 2.3.1 Personalized Medicine Industry Trends
    • 2.3.2 Personalized Medicine Market Drivers
    • 2.3.3 Personalized Medicine Market Challenges
    • 2.3.4 Personalized Medicine Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Personalized Medicine Players by Revenue
    • 3.1.1 Global Top Personalized Medicine Players by Revenue (2017-2022)
    • 3.1.2 Global Personalized Medicine Revenue Market Share by Players (2017-2022)
  • 3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Personalized Medicine Revenue
  • 3.4 Global Personalized Medicine Market Concentration Ratio
    • 3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2021
  • 3.5 Personalized Medicine Key Players Head office and Area Served
  • 3.6 Key Players Personalized Medicine Product Solution and Service
  • 3.7 Date of Enter into Personalized Medicine Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicine Breakdown Data by Type

  • 4.1 Global Personalized Medicine Historic Market Size by Type (2017-2022)
  • 4.2 Global Personalized Medicine Forecasted Market Size by Type (2023-2028)

5 Personalized Medicine Breakdown Data by Application

  • 5.1 Global Personalized Medicine Historic Market Size by Application (2017-2022)
  • 5.2 Global Personalized Medicine Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Personalized Medicine Market Size (2017-2028)
  • 6.2 North America Personalized Medicine Market Size by Type
    • 6.2.1 North America Personalized Medicine Market Size by Type (2017-2022)
    • 6.2.2 North America Personalized Medicine Market Size by Type (2023-2028)
    • 6.2.3 North America Personalized Medicine Market Share by Type (2017-2028)
  • 6.3 North America Personalized Medicine Market Size by Application
    • 6.3.1 North America Personalized Medicine Market Size by Application (2017-2022)
    • 6.3.2 North America Personalized Medicine Market Size by Application (2023-2028)
    • 6.3.3 North America Personalized Medicine Market Share by Application (2017-2028)
  • 6.4 North America Personalized Medicine Market Size by Country
    • 6.4.1 North America Personalized Medicine Market Size by Country (2017-2022)
    • 6.4.2 North America Personalized Medicine Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Personalized Medicine Market Size (2017-2028)
  • 7.2 Europe Personalized Medicine Market Size by Type
    • 7.2.1 Europe Personalized Medicine Market Size by Type (2017-2022)
    • 7.2.2 Europe Personalized Medicine Market Size by Type (2023-2028)
    • 7.2.3 Europe Personalized Medicine Market Share by Type (2017-2028)
  • 7.3 Europe Personalized Medicine Market Size by Application
    • 7.3.1 Europe Personalized Medicine Market Size by Application (2017-2022)
    • 7.3.2 Europe Personalized Medicine Market Size by Application (2023-2028)
    • 7.3.3 Europe Personalized Medicine Market Share by Application (2017-2028)
  • 7.4 Europe Personalized Medicine Market Size by Country
    • 7.4.1 Europe Personalized Medicine Market Size by Country (2017-2022)
    • 7.4.2 Europe Personalized Medicine Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Personalized Medicine Market Size (2017-2028)
  • 8.2 Asia-Pacific Personalized Medicine Market Size by Type
    • 8.2.1 Asia-Pacific Personalized Medicine Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Personalized Medicine Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Personalized Medicine Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Personalized Medicine Market Size by Application
    • 8.3.1 Asia-Pacific Personalized Medicine Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Personalized Medicine Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Personalized Medicine Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Personalized Medicine Market Size by Region
    • 8.4.1 Asia-Pacific Personalized Medicine Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Personalized Medicine Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Personalized Medicine Market Size (2017-2028)
  • 9.2 Latin America Personalized Medicine Market Size by Type
    • 9.2.1 Latin America Personalized Medicine Market Size by Type (2017-2022)
    • 9.2.2 Latin America Personalized Medicine Market Size by Type (2023-2028)
    • 9.2.3 Latin America Personalized Medicine Market Share by Type (2017-2028)
  • 9.3 Latin America Personalized Medicine Market Size by Application
    • 9.3.1 Latin America Personalized Medicine Market Size by Application (2017-2022)
    • 9.3.2 Latin America Personalized Medicine Market Size by Application (2023-2028)
    • 9.3.3 Latin America Personalized Medicine Market Share by Application (2017-2028)
  • 9.4 Latin America Personalized Medicine Market Size by Country
    • 9.4.1 Latin America Personalized Medicine Market Size by Country (2017-2022)
    • 9.4.2 Latin America Personalized Medicine Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Personalized Medicine Market Size (2017-2028)
  • 10.2 Middle East & Africa Personalized Medicine Market Size by Type
    • 10.2.1 Middle East & Africa Personalized Medicine Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Personalized Medicine Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Personalized Medicine Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Personalized Medicine Market Size by Application
    • 10.3.1 Middle East & Africa Personalized Medicine Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Personalized Medicine Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Personalized Medicine Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Personalized Medicine Market Size by Country
    • 10.4.1 Middle East & Africa Personalized Medicine Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Personalized Medicine Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Personalized Medicine Introduction
    • 11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2017-2022)
    • 11.1.5 Abbott Laboratories Recent Developments
  • 11.2 Agilent Technologies
    • 11.2.1 Agilent Technologies Company Details
    • 11.2.2 Agilent Technologies Business Overview
    • 11.2.3 Agilent Technologies Personalized Medicine Introduction
    • 11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2017-2022)
    • 11.2.5 Agilent Technologies Recent Developments
  • 11.3 Amgen
    • 11.3.1 Amgen Company Details
    • 11.3.2 Amgen Business Overview
    • 11.3.3 Amgen Personalized Medicine Introduction
    • 11.3.4 Amgen Revenue in Personalized Medicine Business (2017-2022)
    • 11.3.5 Amgen Recent Developments
  • 11.4 Astellas Pharma
    • 11.4.1 Astellas Pharma Company Details
    • 11.4.2 Astellas Pharma Business Overview
    • 11.4.3 Astellas Pharma Personalized Medicine Introduction
    • 11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2017-2022)
    • 11.4.5 Astellas Pharma Recent Developments
  • 11.5 Astrazeneca
    • 11.5.1 Astrazeneca Company Details
    • 11.5.2 Astrazeneca Business Overview
    • 11.5.3 Astrazeneca Personalized Medicine Introduction
    • 11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2017-2022)
    • 11.5.5 Astrazeneca Recent Developments
  • 11.6 Bayer AG
    • 11.6.1 Bayer AG Company Details
    • 11.6.2 Bayer AG Business Overview
    • 11.6.3 Bayer AG Personalized Medicine Introduction
    • 11.6.4 Bayer AG Revenue in Personalized Medicine Business (2017-2022)
    • 11.6.5 Bayer AG Recent Developments
  • 11.7 Celgene Corporation
    • 11.7.1 Celgene Corporation Company Details
    • 11.7.2 Celgene Corporation Business Overview
    • 11.7.3 Celgene Corporation Personalized Medicine Introduction
    • 11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2017-2022)
    • 11.7.5 Celgene Corporation Recent Developments
  • 11.8 Glaxosmithkline Plc
    • 11.8.1 Glaxosmithkline Plc Company Details
    • 11.8.2 Glaxosmithkline Plc Business Overview
    • 11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
    • 11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2017-2022)
    • 11.8.5 Glaxosmithkline Plc Recent Developments
  • 11.9 Illumina
    • 11.9.1 Illumina Company Details
    • 11.9.2 Illumina Business Overview
    • 11.9.3 Illumina Personalized Medicine Introduction
    • 11.9.4 Illumina Revenue in Personalized Medicine Business (2017-2022)
    • 11.9.5 Illumina Recent Developments
  • 11.10 Johnson & Johnson
    • 11.10.1 Johnson & Johnson Company Details
    • 11.10.2 Johnson & Johnson Business Overview
    • 11.10.3 Johnson & Johnson Personalized Medicine Introduction
    • 11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2017-2022)
    • 11.10.5 Johnson & Johnson Recent Developments
  • 11.11 Laboratory Corporation
    • 11.11.1 Laboratory Corporation Company Details
    • 11.11.2 Laboratory Corporation Business Overview
    • 11.11.3 Laboratory Corporation Personalized Medicine Introduction
    • 11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2017-2022)
    • 11.11.5 Laboratory Corporation Recent Developments
  • 11.12 Merck
    • 11.12.1 Merck Company Details
    • 11.12.2 Merck Business Overview
    • 11.12.3 Merck Personalized Medicine Introduction
    • 11.12.4 Merck Revenue in Personalized Medicine Business (2017-2022)
    • 11.12.5 Merck Recent Developments
  • 11.13 Novartis AG
    • 11.13.1 Novartis AG Company Details
    • 11.13.2 Novartis AG Business Overview
    • 11.13.3 Novartis AG Personalized Medicine Introduction
    • 11.13.4 Novartis AG Revenue in Personalized Medicine Business (2017-2022)
    • 11.13.5 Novartis AG Recent Developments
  • 11.14 Roche Holding AG
    • 11.14.1 Roche Holding AG Company Details
    • 11.14.2 Roche Holding AG Business Overview
    • 11.14.3 Roche Holding AG Personalized Medicine Introduction
    • 11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2017-2022)
    • 11.14.5 Roche Holding AG Recent Developments
  • 11.15 Siemens AG
    • 11.15.1 Siemens AG Company Details
    • 11.15.2 Siemens AG Business Overview
    • 11.15.3 Siemens AG Personalized Medicine Introduction
    • 11.15.4 Siemens AG Revenue in Personalized Medicine Business (2017-2022)
    • 11.15.5 Siemens AG Recent Developments
  • 11.16 Takeda Pharmaceutical Company Limited
    • 11.16.1 Takeda Pharmaceutical Company Limited Company Details
    • 11.16.2 Takeda Pharmaceutical Company Limited Business Overview
    • 11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
    • 11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2017-2022)
    • 11.16.5 Takeda Pharmaceutical Company Limited Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Personalized Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Personalized Medicine Diagnostics
  • Table 3. Key Players of Personalized Medical Care
  • Table 4. Key Players of Personalized Medicine Therapeutics
  • Table 5. Key Players of Personalized Nutrition and Wellness
  • Table 6. Global Personalized Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Personalized Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Personalized Medicine Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Personalized Medicine Market Share by Region (2017-2022)
  • Table 10. Global Personalized Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Personalized Medicine Market Share by Region (2023-2028)
  • Table 12. Personalized Medicine Market Trends
  • Table 13. Personalized Medicine Market Drivers
  • Table 14. Personalized Medicine Market Challenges
  • Table 15. Personalized Medicine Market Restraints
  • Table 16. Global Personalized Medicine Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Personalized Medicine Revenue Share by Players (2017-2022)
  • Table 18. Global Top Personalized Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine as of 2021)
  • Table 19. Ranking of Global Top Personalized Medicine Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Personalized Medicine Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Personalized Medicine Product Solution and Service
  • Table 23. Date of Enter into Personalized Medicine Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Personalized Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Personalized Medicine Revenue Market Share by Type (2017-2022)
  • Table 27. Global Personalized Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Personalized Medicine Revenue Market Share by Type (2023-2028)
  • Table 29. Global Personalized Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Personalized Medicine Revenue Share by Application (2017-2022)
  • Table 31. Global Personalized Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Personalized Medicine Revenue Share by Application (2023-2028)
  • Table 33. North America Personalized Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Personalized Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Personalized Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Personalized Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Personalized Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Personalized Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Personalized Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Personalized Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Personalized Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Personalized Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Personalized Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Personalized Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Personalized Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Personalized Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Personalized Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Personalized Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Personalized Medicine Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Personalized Medicine Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Personalized Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Personalized Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Personalized Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Personalized Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Personalized Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Personalized Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Personalized Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Personalized Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Personalized Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Personalized Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Personalized Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Personalized Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Abbott Laboratories Company Details
  • Table 64. Abbott Laboratories Business Overview
  • Table 65. Abbott Laboratories Personalized Medicine Product
  • Table 66. Abbott Laboratories Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 67. Abbott Laboratories Recent Developments
  • Table 68. Agilent Technologies Company Details
  • Table 69. Agilent Technologies Business Overview
  • Table 70. Agilent Technologies Personalized Medicine Product
  • Table 71. Agilent Technologies Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 72. Agilent Technologies Recent Developments
  • Table 73. Amgen Company Details
  • Table 74. Amgen Business Overview
  • Table 75. Amgen Personalized Medicine Product
  • Table 76. Amgen Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 77. Amgen Recent Developments
  • Table 78. Astellas Pharma Company Details
  • Table 79. Astellas Pharma Business Overview
  • Table 80. Astellas Pharma Personalized Medicine Product
  • Table 81. Astellas Pharma Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 82. Astellas Pharma Recent Developments
  • Table 83. Astrazeneca Company Details
  • Table 84. Astrazeneca Business Overview
  • Table 85. Astrazeneca Personalized Medicine Product
  • Table 86. Astrazeneca Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 87. Astrazeneca Recent Developments
  • Table 88. Bayer AG Company Details
  • Table 89. Bayer AG Business Overview
  • Table 90. Bayer AG Personalized Medicine Product
  • Table 91. Bayer AG Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 92. Bayer AG Recent Developments
  • Table 93. Celgene Corporation Company Details
  • Table 94. Celgene Corporation Business Overview
  • Table 95. Celgene Corporation Personalized Medicine Product
  • Table 96. Celgene Corporation Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 97. Celgene Corporation Recent Developments
  • Table 98. Glaxosmithkline Plc Company Details
  • Table 99. Glaxosmithkline Plc Business Overview
  • Table 100. Glaxosmithkline Plc Personalized Medicine Product
  • Table 101. Glaxosmithkline Plc Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 102. Glaxosmithkline Plc Recent Developments
  • Table 103. Illumina Company Details
  • Table 104. Illumina Business Overview
  • Table 105. Illumina Personalized Medicine Product
  • Table 106. Illumina Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 107. Illumina Recent Developments
  • Table 108. Johnson & Johnson Company Details
  • Table 109. Johnson & Johnson Business Overview
  • Table 110. Johnson & Johnson Personalized Medicine Product
  • Table 111. Johnson & Johnson Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 112. Johnson & Johnson Recent Developments
  • Table 113. Laboratory Corporation Company Details
  • Table 114. Laboratory Corporation Business Overview
  • Table 115. Laboratory Corporation Personalized Medicine Product
  • Table 116. Laboratory Corporation Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 117. Laboratory Corporation Recent Developments
  • Table 118. Merck Company Details
  • Table 119. Merck Business Overview
  • Table 120. Merck Personalized Medicine Product
  • Table 121. Merck Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 122. Merck Recent Developments
  • Table 123. Novartis AG Company Details
  • Table 124. Novartis AG Business Overview
  • Table 125. Novartis AG Personalized Medicine Product
  • Table 126. Novartis AG Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 127. Novartis AG Recent Developments
  • Table 128. Roche Holding AG Company Details
  • Table 129. Roche Holding AG Business Overview
  • Table 130. Roche Holding AG Personalized Medicine Product
  • Table 131. Roche Holding AG Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 132. Roche Holding AG Recent Developments
  • Table 133. Siemens AG Company Details
  • Table 134. Siemens AG Business Overview
  • Table 135. Siemens AG Personalized Medicine Product
  • Table 136. Siemens AG Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 137. Siemens AG Recent Developments
  • Table 138. Takeda Pharmaceutical Company Limited Company Details
  • Table 139. Takeda Pharmaceutical Company Limited Business Overview
  • Table 140. Takeda Pharmaceutical Company Limited Personalized Medicine Product
  • Table 141. Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2017-2022) & (US$ Million)
  • Table 142. Takeda Pharmaceutical Company Limited Recent Developments
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Personalized Medicine Market Share by Type: 2021 VS 2028
  • Figure 2. Personalized Medicine Diagnostics Features
  • Figure 3. Personalized Medical Care Features
  • Figure 4. Personalized Medicine Therapeutics Features
  • Figure 5. Personalized Nutrition and Wellness Features
  • Figure 6. Global Personalized Medicine Market Share by Application: 2021 VS 2028
  • Figure 7. Oncology Case Studies
  • Figure 8. Central Nervous System (CNS) Case Studies
  • Figure 9. Immunology Case Studies
  • Figure 10. Respiratory Case Studies
  • Figure 11. Other Applications Case Studies
  • Figure 12. Personalized Medicine Report Years Considered
  • Figure 13. Global Personalized Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 14. Global Personalized Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 15. Global Personalized Medicine Market Share by Region: 2021 VS 2028
  • Figure 16. Global Personalized Medicine Market Share by Players in 2021
  • Figure 17. Global Top Personalized Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine as of 2021)
  • Figure 18. The Top 10 and 5 Players Market Share by Personalized Medicine Revenue in 2021
  • Figure 19. North America Personalized Medicine Market Size YoY (2017-2028) & (US$ Million)
  • Figure 20. North America Personalized Medicine Market Size Market Share by Type (2017-2028)
  • Figure 21. North America Personalized Medicine Market Size Market Share by Application (2017-2028)
  • Figure 22. North America Personalized Medicine Market Size Share by Country (2017-2028)
  • Figure 23. United States Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Canada Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe Personalized Medicine Market Size YoY (2017-2028) & (US$ Million)
  • Figure 26. Europe Personalized Medicine Market Size Market Share by Type (2017-2028)
  • Figure 27. Europe Personalized Medicine Market Size Market Share by Application (2017-2028)
  • Figure 28. Europe Personalized Medicine Market Size Share by Country (2017-2028)
  • Figure 29. Germany Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. France Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. U.K. Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Italy Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Russia Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Nordic Countries Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific Personalized Medicine Market Size YoY (2017-2028) & (US$ Million)
  • Figure 36. Asia Pacific Personalized Medicine Market Size Market Share by Type (2017-2028)
  • Figure 37. Asia Pacific Personalized Medicine Market Size Market Share by Application (2017-2028)
  • Figure 38. Asia Pacific Personalized Medicine Market Size Share by Region (2017-2028)
  • Figure 39. China Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Japan Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. South Korea Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Southeast Asia Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. India Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Australia Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. Latin America Personalized Medicine Market Size YoY (2017-2028) & (US$ Million)
  • Figure 46. Latin America Personalized Medicine Market Size Market Share by Type (2017-2028)
  • Figure 47. Latin America Personalized Medicine Market Size Market Share by Application (2017-2028)
  • Figure 48. Latin America Personalized Medicine Market Size Share by Country (2017-2028)
  • Figure 49. Mexico Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Brazil Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Middle East & Africa Personalized Medicine Market Size YoY (2017-2028) & (US$ Million)
  • Figure 52. Middle East and Africa Personalized Medicine Market Size Market Share by Type (2017-2028)
  • Figure 53. Middle East and Africa Personalized Medicine Market Size Market Share by Application (2017-2028)
  • Figure 54. Middle East and Africa Personalized Medicine Market Size Share by Country (2017-2028)
  • Figure 55. Turkey Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Saudi Arabia Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. UAE Personalized Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Abbott Laboratories Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 59. Agilent Technologies Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 60. Amgen Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 61. Astellas Pharma Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 62. Astrazeneca Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 63. Bayer AG Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 64. Celgene Corporation Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 65. Glaxosmithkline Plc Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 66. Illumina Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 67. Johnson & Johnson Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 68. Laboratory Corporation Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 69. Merck Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 70. Novartis AG Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 71. Roche Holding AG Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 72. Siemens AG Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 73. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Personalized Medicine Business (2017-2022)
  • Figure 74. Bottom-up and Top-down Approaches for This Report
  • Figure 75. Data Triangulation
  • Figure 76. Key Executives Interviewed